- Home
- WRBY vs HRMY Comparison
WRBY vs HRMY Comparison
Compare WRBY & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRBY
- HRMY
- Stock Information
- Founded
- WRBY 2010
- HRMY 2017
- Country
- WRBY United States
- HRMY United States
- Employees
- WRBY N/A
- HRMY N/A
- Industry
- WRBY Ophthalmic Goods
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- WRBY Health Care
- HRMY Health Care
- Exchange
- WRBY Nasdaq
- HRMY Nasdaq
- Market Cap
- WRBY 2.1B
- HRMY 2.0B
- IPO Year
- WRBY 2021
- HRMY 2020
- Fundamental
- Price
- WRBY $20.79
- HRMY $35.31
- Analyst Decision
- WRBY Buy
- HRMY Strong Buy
- Analyst Count
- WRBY 15
- HRMY 9
- Target Price
- WRBY $23.33
- HRMY $54.22
- AVG Volume (30 Days)
- WRBY 3.5M
- HRMY 738.5K
- Earning Date
- WRBY 05-08-2025
- HRMY 05-06-2025
- Dividend Yield
- WRBY N/A
- HRMY N/A
- EPS Growth
- WRBY N/A
- HRMY 13.13
- EPS
- WRBY N/A
- HRMY 2.62
- Revenue
- WRBY $795,094,000.00
- HRMY $744,852,000.00
- Revenue This Year
- WRBY $15.94
- HRMY $20.35
- Revenue Next Year
- WRBY $13.73
- HRMY $17.42
- P/E Ratio
- WRBY N/A
- HRMY $13.46
- Revenue Growth
- WRBY 13.94
- HRMY 20.62
- 52 Week Low
- WRBY $12.46
- HRMY $26.47
- 52 Week High
- WRBY $28.68
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- WRBY 62.11
- HRMY 61.62
- Support Level
- WRBY $19.38
- HRMY $33.47
- Resistance Level
- WRBY $21.71
- HRMY $35.35
- Average True Range (ATR)
- WRBY 1.14
- HRMY 1.09
- MACD
- WRBY 0.24
- HRMY -0.01
- Stochastic Oscillator
- WRBY 73.23
- HRMY 70.34
About WRBY Warby Parker Inc.
Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.